- Alvotech press release ( NASDAQ: ALVO ): 1H GAAP EPS of -$1.02.
- Revenue of $40.1M (+1905.0% Y/Y).
- Cash and cash equivalents is of $128.4M
For further details see:
Alvotech GAAP EPS of -$1.02, revenue of $40.1MFor further details see:
Alvotech GAAP EPS of -$1.02, revenue of $40.1MMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Alvotech Company Name:
ALVO Stock Symbol:
Market:
U.S. stocks were mixed, with the Nasdaq Composite falling over 100 points on Friday. Shares of Fifth Third Bancorp (NASDAQ:FITB) rose during Friday...
2024-04-19 13:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Alvotech, in agreement with Teva Pharmaceuticals, has signed an agreement with a strategic partner to bring to the U.S. market the newly FDA approved high-concentration interchangeable biosimilar to Humira ® The agreement broadens patient access and further commitment to avai...